Also, patients with chronic lymphocytic leukemia (CLL) exhibit an upregulation of LAG-3 on leukemic blasts, NK cells and T lymphocytes, accompanied by high amounts of soluble LAG-3 (sLAG-3) in plasma, that correlated with impaired outcome. Here, LAG3 is linked to B-cell chronic lymphocytic leukemia.